1.
Eshwara VK, Mukhopadhyay C, Rello J. Community-acquired bacterial pneumonia in adults: an update. Indian J Med Res. 2020;151(4):287-302.
2.
Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021;217:107663.
3.
Rothberg MB. Community-acquired pneumonia. Ann Intern Med. 2022; 175(4):ITC49-ITC64.
4.
Heo JY, Song JY. Disease burden and etiologic distribution of community-acquired pneumonia in adults: evolving epidemiology in the era of pneumococcal conjugate vaccines. Infect Chemother. 2018;50(4): 287-300.
5.
Modi AR, Kovacs CS. Community-acquired pneumonia: strategies for triage and treatment. Cleve Clin J Med. 2020;87(3):145-151.
6.
Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-acquired pneumonia: a review. JAMA. 2024;332(15):1282-1295.
7.
Martin-Loeches I, Torres A, Nagavci B, et al. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.Intensive Care Med. 2023;49(8):1040-1041.
8.
Niederman MS, Torres A. Severe community-acquired pneumonia. Eur Respir Rev. 2022;31(166):220123.
9.
Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016;35:200-205.
10.
Gallardo A, Zamarrón-López E, Deloya-Tomas E, Pérez-Nieto OR. Advantages and limitations of the ROX index. Pulmonology. 2022;28(4): 320-321.
11.
Praphruetkit N, Boonchana N, Monsomboon A, Ruangsomboon O. ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study. Int J Emerg Med. 2023;16(1):3.
12.
Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302-1318.
13.
DeLaney M, Khoury C. Community-acquired pneumonia in the emergency department. Emerg Med Pract. 2021;23(2):1-24.
14.
Olson G, Davis AM. Diagnosis and treatment of adults with community-acquired pneumonia. JAMA. 2020;323(9):885-886.
15.
Yau CE, Lee DYX, Vasudevan A, et al. Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2023;27(1):320.
16.
Hancı P, Uysal A, Yüksel B, İnal V. Rox index dynamics according to high flow nasal cannula success in intensive care unit patients with COVID-19-related acute respiratory failure. Balkan Med J. 2023;40(2):111-116.
17.
Colaianni-Alfonso N, Montiel GC, Castro-Sayat M, Roca O, Grieco DL. ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19. Intensive Care Med. 2022;48(12):1818-1819.
18.
Zaboli A, Ausserhofer D, Pfeifer N, et al. The ROX index can be a useful tool for the triage evaluation of COVID-19 patients with dyspnoea. J Adv Nurs. 2021;77(8):3361-3369.
19.
Reyes LF, Bastidas Goyes A, Tuta Quintero EA, et al. Validity of the ROX index in predicting invasive mechanical ventilation requirement in pneumonia. BMJ Open Respir Res. 2022;9(1):e001320.
20.
Suliman LA, Abdelgawad TT, Farrag NS, Abdelwahab HW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med. 2021;89(1):1-7.